The Michael J. Fox Foundation Parkinson's Podcast
Summary: Subscribe for coverage and analysis of current neurology/brain research, patient and caregiver profiles, drug development strategy, pioneering nonprofit management and other topics of interest in a wide-ranging series of conversations hosted by journalist and Parkinson’s patient Dave Iverson.
- Visit Website
- RSS
- Artist: Michael J. Fox Foundation
- Copyright: Copyright 2013
Podcasts:
Dr. Kathleen Shannon of Rush University talks to Dave Iverson about the need for a definitive Parkinson's diagnostic test, what researchers are doing to develop one and how patients can help.
Dr. Kathleen Shannon of Rush University talks to Dave Iverson about the need for a definitive Parkinson's diagnostic test, what researchers are doing to develop one and how patients can help.
The SURE-PD study published in JAMA Neurology reports that with medical supervision, it is possible to safely raise levels of the antioxidant urate by taking the urate precursor inosine.
The SURE-PD study published in JAMA Neurology reports that with medical supervision, it is possible to safely raise levels of the antioxidant urate by taking the urate precursor inosine.
The Michael J. Fox Foundation Contributing Editor Dave Iverson speaks with Kalpana Merchant, PhD of Eli Lilly and Company about the latest in Parkinson's disease research.
The Michael J. Fox Foundation Contributing Editor Dave Iverson speaks with Kalpana Merchant, PhD of Eli Lilly and Company about the latest in Parkinson's disease research.
Researchers are improving on the existing DBS technologyan implanted electrode delivers electrical pulses to stimulate or block brain signalsand how we use it.
Researchers are improving on the existing DBS technologyan implanted electrode delivers electrical pulses to stimulate or block brain signalsand how we use it.
Levels of alpha-synuclein in the brainmeasured through imaging toolscould be a biomarker that would help researchers diagnose the disease better and test potential therapies faster.
Levels of alpha-synuclein in the brainmeasured through imaging toolscould be a biomarker that would help researchers diagnose the disease better and test potential therapies faster.
Contributing Editor Dave Iverson reports on the new technology that partnership will employ and the current state of stem cell research in Parkinson's disease. He speaks
Contributing Editor Dave Iverson reports on the new technology that partnership will employ and the current state of stem cell research in Parkinson's disease. He speaks
While much research into Parkinson's disease (PD) focuses on improving dopamine supply, there is an emerging scientific understanding that Parkinson's goes well beyond the dopamine system.
While much research into Parkinson's disease (PD) focuses on improving dopamine supply, there is an emerging scientific understanding that Parkinson's goes well beyond the dopamine system.
The evolution of our understanding of genetics' role in Parkinson's disease (PD) and how that understanding will translate into drug discovery is the topic of a new podcast and upcoming Webinar.
